10.1111/jns.12347 8 AugustoL
Several GLS inhibitors have been developed, among which CB-839 is currently undergoing clinical trials as a potent, orally bioavailable GLS-selective inhibitor for the treatment of various cancers, including TNBC, NSCLC, and colon cancer (NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600)
This often results in poor drug loading and requires the use of ionic surfactants that can irritate the ocular surface [353, 354]
The purpose of this article is solely educational to share which supplements they advise in general or take themselves.Naturecan offers some of the key ingredients of these supplements that are highlighted in their regimens
Another notable benefit is its effect on skin health